ZRZ Bioenergy Adjusts Evaluation Score Amidst Strong Yearly Performance and Financial Concerns

ZRZ Bioenergy, a microcap company in the commodity chemicals industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in the technical trends observed in the stock's performance metrics.
The stock's current price stands at 408.00, slightly below the previous close of 410.00. Over the past year, ZRZ Bioenergy has demonstrated a notable return of 72.19%, significantly outperforming the Sensex, which recorded a return of 3.96% in the same period. However, the company has faced challenges, including operating losses and a weak long-term fundamental strength, with an annual growth rate of operating profit at just 2.83% over the last five years.

The stock's volatility is highlighted by its 52-week range, with a high of 540.60 and a low of 224.35. Additionally, the company's debt to EBITDA ratio indicates a low ability to service debt, raising concerns about its financial stability. Despite these challenges, ZRZ Bioenergy has shown market-beating performance over the long term, particularly in the last three years.

For more insights on ZRZ Bioenergy's financial trends, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.